Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer
CEO Action Plan: The Next 48 Hours Balancing Ethics, Legal Duty, Patient Safety, and Business Sustainability Hour 0–6: Assess the Situation and Secure Critical Data Actions: Call Emergency Secure Meeting (Virtual) with Chief Medical Officer (CMO), Chief Scientific Officer (CSO), Head of Regulatory Affairs, and Lead…Read the full answer